On June 1, 2022 Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, reported Scott Hutton, Chief Executive Officer of Biodesix, will present at the 42nd Annual William Blair Growth Stock Conference being held June 6-9, 2022 at the Lowes Chicago Hotel in Chicago, IL (Press release, Biodesix, JUN 1, 2022, View Source [SID1234615326]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
42nd Annual William Blair Growth Stock Conference
Date: Wednesday, June 8, 2022
Time: 9:20 a.m. CT
In addition to the presentation, the management team will host investor meetings. Investors participating in the conference who are interested in meeting with Biodesix management should contact their William Blair representative.
A live webcast of the presentation will be available under "News & Events" in the Investors section of the Company’s website at www.biodesix.com. A replay will be available for 90 days following the event.